OTC
Stada expands OTC business with portfolio of GSK drugs
Richard Staines
allergy, dermatology, GlaxoSmithKline, M&A, OTC, Stada
0 Comment
News/ News/ Sales and Marketing
Takeda nets $660m from product selloff to Germany’s Stada
Phil Taylor
emerging markets, generic, OTC, Russia, Stada, Takeda
0 Comment
GSK/Pfizer form consumer health joint venture
Richard Staines
consumer health, GlaxoSmithKline, OTC, Pfizer
0 Comment
GSK to pay $13bn for Novartis stake in OTC joint venture
Richard Staines
GlaxoSmithKline, M&A, Novartis, OTC
0 Comment
The Pharmacy Show 2018
Jessica Carruthers
OTC, pharmacist, pharmacy
0 Comment
A dedicated Pharmacy show held in South Africa
M&A/ News/ News/ Pfizer/ Sales and Marketing
GSK left as sole bidder for Pfizer consumer health unit
Richard Staines
GlaxoSmithKline, M&A, OTC, Pfizer, Reckitt Benckiser
0 Comment
GSK is left as sole bidder amid speculation that the sale is off.
GlaxoSmithKline/ Healthcare/ M&A/ News
A Pfizer consumer buyout won’t detract from pharma business, says GSK chief
Richard Staines
GlaxoSmithKline, JP Morgan 2018, M&A, OTC, Pfizer
0 Comment
Walmsley has axed 40% of management team in shake-up